DiaMedica Announces the Appointment of Dr. Mark Robbins as Vice President, Clinical and Regulatory Affairs
MINNEAPOLIS, MINNESOTA--(Marketwire - Jan. 9, 2013) - DiaMedica (TSX VENTURE:DMA) is pleased to announce that Mark Robbins, Ph.D., J.D., has...